AVIR - Atea gains after mid-stage data for lead asset in Hepatitis C
2024-01-09 12:50:43 ET
More on Atea Pharmaceuticals
- Atea Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Atea Pharmaceuticals, Inc. (AVIR) Q3 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Atea Pharmaceuticals
- Historical earnings data for Atea Pharmaceuticals
- Financial information for Atea Pharmaceuticals
For further details see:
Atea gains after mid-stage data for lead asset in Hepatitis C